AI-generated summary
The authors evaluated a non-ablative fractional 1565 nm laser in 16 adults with striae distensae albae, given three treatments about four weeks apart. They report a significant reduction in lesion depth and skin irregularity measured by three-dimensional analysis, along with improved patient ratings. The study was prospective but small, without a control group, so the authors' conclusions about safety and effect are limited.
- Participants
- 16
- Who or what was studied
- 16 Caucasian adults with striae distensae albae
- Wavelengths
- 1565 nm
- Limits stated in the abstract
- Small uncontrolled prospective study of 16 patients without a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1565 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.